Changeflow GovPing Healthcare European Patent EP4262629A1 for Valvular Regurg...
Routine Notice Added Final

European Patent EP4262629A1 for Valvular Regurgitation Treatment

Favicon for changeflow.com ChangeBridge: EPO Bulletin - Prosthetics (A61F)
Published March 11th, 2026
Detected March 26th, 2026
Email

Summary

The European Patent Office has published patent application EP4262629A1 for a device, system, and method for treating valvular regurgitation. The patent was applied for by Polares Medical Inc. and is designated for use in multiple European countries.

What changed

The European Patent Office (EPO) has published patent application EP4262629A1, titled "DEVICE, SYSTEM, AND METHOD FOR TRANSCATHETER TREATMENT OF VALVULAR REGURGITATION WITH SECONDARY ANCHORS." This publication relates to novel medical technology for treating valvular regurgitation, with Polares Medical Inc. listed as the applicant. The patent is designated for use across numerous European states.

This patent publication represents a new intellectual property filing and does not impose immediate regulatory obligations on regulated entities. Compliance officers should note this as a development in medical device technology within the prosthetics and cardiovascular treatment sectors. No compliance actions or deadlines are associated with this patent publication itself.

Source document (simplified)

← EPO Patent Bulletin

DEVICE, SYSTEM, AND METHOD FOR TRANSCATHETER TREATMENT OF VALVULAR REGURGITATION WITH SECONDARY ANCHORS

Publication EP4262629A1 Kind: A1 Mar 11, 2026

Applicants

Polares Medical Inc.

Inventors

KHAIRKHAHAN, Alexander K., ESSINGER, Jacques, KLENK, Alan

IPC Classifications

A61F 2/24 20060101AFI20240924BHEP A61B 17/068 20060101ALI20240924BHEP A61B 17/064 20060101ALI20240924BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Named provisions

DEVICE, SYSTEM, AND METHOD FOR TRANSCATHETER TREATMENT OF VALVULAR REGURGITATION WITH SECONDARY ANCHORS

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
EPO
Published
March 11th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
EP4262629A1

Who this affects

Applies to
Drug manufacturers Medical device makers Healthcare providers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Medical Device Development Cardiovascular Treatment
Geographic scope
European Union EU

Taxonomy

Primary area
Healthcare
Operational domain
Product Development
Topics
Medical Devices Intellectual Property

Get Healthcare alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Prosthetics (A61F) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.